S&P 500
$5,842.01
-0.0%
-$2.60
DJI
41,859.09
-0.0%
-1.35
NASDAQ
$18,925.73
+0.3%
+$53.09
Bitcoin
111,295.00
+0.7%
+745.55
AAPL
$201.16
-0.5%
-$0.93
AMZN
$202.96
+0.9%
+$1.84
GOOG
$171.96
+1.1%
+$1.90
META
$636.81
+0.2%
+$1.31
MSFT
$454.60
+0.4%
+$2.03
NVDA
$132.90
+0.8%
+$1.10
TSLA
$341.59
+2.1%
+$6.97
Compass Therapeutics (NASDAQ: CMPX)
$2.11
(2.4%)
$0.05
Price as of May 22, 2025, 3:53 p.m. ET
Compass Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Compass Therapeutics Company Info
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. It also focuses on the relationship between angiogenesis, the immune system, and tumor growth. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.